JNJ

Timothy Schmid

Known title: EVP, WW Chair, MedTechCIK: 0001998491

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Johnson & Johnson: Key Takeaways for Long-Term Investors. Recent coverage highlighted three takeaways for long‑term investors in Johnson & Johnson. The article notes the company's steady dividend yield of about 3.1% and its diversified healthcare portfolio. It also points to a relatively high price‑to‑earnings multiple, suggesting expectations of continued growth. These points are relevant as the stock trades near a long‑standing support level.

this person other insiders at JNJ

Transaction History

JNJ▲ Buy$1.5M
JNJ▼ Sell$3.0M
JNJ▲ Buy$3.4M
JNJ▼ Sell$6.2M
JNJ▼ Sell$325K
JNJ▼ Sell$3.3M
JNJ▲ Buy$1.2M
JNJ▼ Sell$2.2M
JNJ▲ Buy$1.6M
JNJ▲ Buy$0
JNJ▼ Sell$4K
JNJ▲ Buy$0
JNJ▼ Sell$109K
JNJ▲ Buy$0
JNJ▼ Sell$2K
JNJ▲ Buy$0
JNJ▼ Sell$444K
JNJ▲ Buy$1.6M
JNJ▼ Sell$2.5M
JNJ▼ Sell$63K
JNJ▲ Buy$0
JNJ▲ Buy$0
JNJ▼ Sell$159K
JNJ▼ Sell$30K
JNJ▲ Buy$0
JNJ▼ Sell$100K
JNJ▲ Buy$0
JNJ▲ Buy$0
JNJ▼ Sell$39K
JNJ▲ Buy$0
JNJ▲ Buy$0
JNJ▼ Sell$454K
JNJ▲ Buy$0
JNJ▼ Sell$156K

We use analytics to understand how market-wall is used. No personal data is sold.